Testicular cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 21: Line 21:
| colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
| colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="3" |Lab findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! rowspan="2" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-
|-
|Pain
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
|Mass
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
!AFP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |AFP
!Beta hCG
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Beta hCG
!p-ALP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |p-ALP
|-
|-
! colspan="15" |Germ Cell tumors
! colspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Germ Cell tumors
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seminoma]]<ref name="pmid26742998">{{cite journal| author=Siegel RL, Miller KD, Jemal A| title=Cancer statistics, 2016. | journal=CA Cancer J Clin | year= 2016 | volume= 66 | issue= 1 | pages= 7-30 | pmid=26742998 | doi=10.3322/caac.21332 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26742998  }}</ref><ref name="pmid9930796">{{cite journal| author=Miller FH, Whitney WS, Fitzgerald SW, Miller EI| title=Seminomas complicating undescended intraabdominal testes in patients with prior negative findings from surgical exploration. | journal=AJR Am J Roentgenol | year= 1999 | volume= 172 | issue= 2 | pages= 425-8 | pmid=9930796 | doi=10.2214/ajr.172.2.9930796 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9930796  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seminoma]]<ref name="pmid26742998">{{cite journal| author=Siegel RL, Miller KD, Jemal A| title=Cancer statistics, 2016. | journal=CA Cancer J Clin | year= 2016 | volume= 66 | issue= 1 | pages= 7-30 | pmid=26742998 | doi=10.3322/caac.21332 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26742998  }}</ref><ref name="pmid9930796">{{cite journal| author=Miller FH, Whitney WS, Fitzgerald SW, Miller EI| title=Seminomas complicating undescended intraabdominal testes in patients with prior negative findings from surgical exploration. | journal=AJR Am J Roentgenol | year= 1999 | volume= 172 | issue= 2 | pages= 425-8 | pmid=9930796 | doi=10.2214/ajr.172.2.9930796 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9930796  }}</ref>
Line 55: Line 55:
* [[Palpable]], nontender unilateral [[testicular]] [[mass]]
* [[Palpable]], nontender unilateral [[testicular]] [[mass]]
* Usually [[homogeneous]] enlargement
* Usually [[homogeneous]] enlargement
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|↑
| style="background: #F5F5F5; padding: 5px;" |↑
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* [[Homogeneous]] hypoechoic intratesticular [[mass]]
* [[Homogeneous]] hypoechoic intratesticular [[mass]]
* [[Cysts]] and [[calcification]] are uncommon
* [[Cysts]] and [[calcification]] are uncommon
* Inhomogenous feature in larger [[mass]]
* Inhomogenous feature in larger [[mass]]
|
| style="background: #F5F5F5; padding: 5px;" |
* Large [[cells]] wit watery [[cytoplasm]]
* Large [[cells]] wit watery [[cytoplasm]]
* Fried egg [[appearance]]
* Fried egg [[appearance]]
Line 93: Line 93:
* [[Abdominal pain]] may be present
* [[Abdominal pain]] may be present
* [[Metastatic]] findings
* [[Metastatic]] findings
|↑*
|  style="background: #F5F5F5; padding: 5px;"|↑*
|↑
| style="background: #F5F5F5; padding: 5px;" |↑
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* Usually hypoechoic [[mass]]
* Usually hypoechoic [[mass]]
* [[Invasion]] to [[tunica albuginea]]
* [[Invasion]] to [[tunica albuginea]]
* Irregular [[calcification]]
* Irregular [[calcification]]
|
| style="background: #F5F5F5; padding: 5px;" |
* Primitive [[epithelial cells]] with marked [[pleomorphism]]
* Primitive [[epithelial cells]] with marked [[pleomorphism]]
* Often mixed [[histopathological]] features ([[solid]], [[papillary]], [[tubular]], pseudoglandular)
* Often mixed [[histopathological]] features ([[solid]], [[papillary]], [[tubular]], pseudoglandular)
Line 126: Line 126:
* Nontender [[mass]]
* Nontender [[mass]]
* Unilateral [[mass]]
* Unilateral [[mass]]
|↑
| style="background: #F5F5F5; padding: 5px;" |↑
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* [[Diffuse]] enlargement of the [[testis]] with a [[heterogeneous]] [[appearance]]
* [[Diffuse]] enlargement of the [[testis]] with a [[heterogeneous]] [[appearance]]
[[MRI]]:
[[MRI]]:
* Areas of [[hemorrhage]] and [[necrosis]]  
* Areas of [[hemorrhage]] and [[necrosis]]  
|
| style="background: #F5F5F5; padding: 5px;" |
* Yellow, [[mucinous]], encapsulated mass
* Yellow, [[mucinous]], encapsulated mass


Line 171: Line 171:
* Nontender [[mass]]
* Nontender [[mass]]
* Unilateral [[mass]]
* Unilateral [[mass]]
|↑
| style="background: #F5F5F5; padding: 5px;" | ↑
|↑
| style="background: #F5F5F5; padding: 5px;" | ↑
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* [[Heterogeneous]], [[cystic]] [[appearance]]
* [[Heterogeneous]], [[cystic]] [[appearance]]
* Irregular [[calcification]]   
* Irregular [[calcification]]   
|
| style="background: #F5F5F5; padding: 5px;" |
* Large, [[heterogeneous]] [[appearance]]
* Large, [[heterogeneous]] [[appearance]]
* Presence of at least 2 [[germ layers]]
* Presence of at least 2 [[germ layers]]
Line 206: Line 206:
* [[Gynecomastia]]
* [[Gynecomastia]]
* [[Hyperthyroidism]] [[symptoms]]
* [[Hyperthyroidism]] [[symptoms]]
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|↑
| style="background: #F5F5F5; padding: 5px;" |↑
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* [[Hemorrhage]] and [[necrosis]]
* [[Hemorrhage]] and [[necrosis]]
* May appear more [[cystic]] inhomogeneous, and [[Calcification|calcified]]
* May appear more [[cystic]] inhomogeneous, and [[Calcification|calcified]]
|
| style="background: #F5F5F5; padding: 5px;"
* Characterized by [[hemorrhagic]] and [[necrotic]] areas
* Characterized by [[hemorrhagic]] and [[necrotic]] areas
* Disordered syncytiotrophoblastic and [[cytotrophoblastic]] elements
* Disordered syncytiotrophoblastic and [[cytotrophoblastic]] elements
Line 237: Line 237:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Physical exam]] findings based on underlying components
* [[Physical exam]] findings based on underlying components
|↑
| style="background: #F5F5F5; padding: 5px;" |↑
|↑
| style="background: #F5F5F5; padding: 5px;" |↑
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Imaging]] findings based on underlying components
* [[Imaging]] findings based on underlying components
|
| style="background: #F5F5F5; padding: 5px;" |
* Variable components depends on [[tumor]]
* Variable components depends on [[tumor]]
* Accompanied with [[necrosis]] and [[hemorrhages]]  
* Accompanied with [[necrosis]] and [[hemorrhages]]  
Line 272: Line 272:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* N/A
* N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|↑
| style="background: #F5F5F5; padding: 5px;" |↑
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* N/A
* N/A
|
| style="background: #F5F5F5; padding: 5px;" |
* [[Proliferation]] of [[neoplastic]] [[germ cells]] in [[seminiferous tubules]]
* [[Proliferation]] of [[neoplastic]] [[germ cells]] in [[seminiferous tubules]]
|-
|-
!Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign/ Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign/ Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Unilateral/Bilateral
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Unilateral/Bilateral
Line 290: Line 290:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam  
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam  
!AFP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |AFP
!Beta hCG
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Beta hCG
!p-ALP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |p-ALP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging  
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging  
!Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-
|-
! colspan="15" |Non-germ cell tumors
! colspan="15" colspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" ||Non-germ cell tumors
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Leydig cell tumor]]<ref name="pmid9808128">{{cite journal| author=Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM| title=Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. | journal=Am J Surg Pathol | year= 1998 | volume= 22 | issue= 11 | pages= 1361-7 | pmid=9808128 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9808128  }}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Leydig cell tumor]]<ref name="pmid9808128">{{cite journal| author=Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM| title=Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. | journal=Am J Surg Pathol | year= 1998 | volume= 22 | issue= 11 | pages= 1361-7 | pmid=9808128 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9808128  }}</ref>
Line 326: Line 326:
* Nontender
* Nontender
* [[Gynecomastia]]
* [[Gynecomastia]]
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* Well-defined, hypoechoic [[solid]] mass
* Well-defined, hypoechoic [[solid]] mass
* [[Cystic]] component
* [[Cystic]] component
* Irregular [[calcification]]
* Irregular [[calcification]]
|
| style="background: #F5F5F5; padding: 5px;" |
* Golden brown color
* Golden brown color
* May have [[cystic]], [[hemorrhagic]], or [[necrotic]] areas
* May have [[cystic]], [[hemorrhagic]], or [[necrotic]] areas
Line 363: Line 363:
* Hyperestrinism is noted in syndromic cases
* Hyperestrinism is noted in syndromic cases
* [[Gynecomastia]]
* [[Gynecomastia]]
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* Large [[cell]] calcifying variant
* Large [[cell]] calcifying variant
* Hypoechoic
* Hypoechoic
|
| style="background: #F5F5F5; padding: 5px;" |
* Solid or hollow tubules divided by [[basement membrane]]
* Solid or hollow tubules divided by [[basement membrane]]


Line 400: Line 400:
* [[Palpable]] [[mass]]
* [[Palpable]] [[mass]]
* Nontender [[mass]]
* Nontender [[mass]]
|↑ or ↓
| style="background: #F5F5F5; padding: 5px;" |↑ or ↓
|↑ or ↓
| style="background: #F5F5F5; padding: 5px;" |↑ or ↓
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* [[Diffuse]] [[testicular]] [[Infiltration (medical)|infiltration]] and enlargement
* [[Diffuse]] [[testicular]] [[Infiltration (medical)|infiltration]] and enlargement
* Hypervascularity  
* Hypervascularity  
* Hypoechoic and [[solid]] lesion
* Hypoechoic and [[solid]] lesion
|
| style="background: #F5F5F5; padding: 5px;" |
* [[Pleomorphic]] [[malignant]] cells  
* [[Pleomorphic]] [[malignant]] cells  
* Large irregular [[nuclei]]
* Large irregular [[nuclei]]
Line 440: Line 440:
* [[Palpable]] [[mass]]
* [[Palpable]] [[mass]]
* Nontender [[mass]]
* Nontender [[mass]]
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
|N/A
| style="background: #F5F5F5; padding: 5px;" |N/A
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
| style="background: #F5F5F5; padding: 5px;" |[[Ultrasound]]:
* Hypoechoic [[mass]]
* Hypoechoic [[mass]]
* [[Solid]] and [[cystic]] [[appearance]]
* [[Solid]] and [[cystic]] [[appearance]]
|
| style="background: #F5F5F5; padding: 5px;" |
* Common features are microfollicular and [[diffuse]]
* Common features are microfollicular and [[diffuse]]
* [[Call-Exner bodies]] in adult type ( eosinophillic material)
* [[Call-Exner bodies]] in adult type ( eosinophillic material)

Revision as of 19:52, 28 January 2019

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer differential diagnosis

CDC on Testicular cancer differential diagnosis

Testicular cancer differential diagnosis in the news

Blogs on Testicular cancer differential diagnosis

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.

Differentiating Testicular cancer from other Diseases

Testicular cancer must be differentiated from:

Diseases Benign/ Malignant Unilateral/Bilateral History Demography Metastasis Genetics Clinical manifestations Para-clinical findings
Symptoms Physical examination Lab findings Imaging Histopathology
Pain Mass AFP Beta hCG p-ALP
Germ Cell tumors
Seminoma[1][2]
  • Most common among age of 15-35 years old
 Stains positively for: - + N/A N/A ↑ Ultrasound:
Embryonal carcinoma[3] Early metastasis to: Stains positively for:

May stain positively for :

+ ± ↑* ↑ N/A Ultrasound:
Yolk sac tumor[4][5]
  • Unilateral
  • Uncommon
 Stains positively for: + + ↑ N/A N/A Ultrasound:

MRI:

  • Schiller-Duval bodies (perivascular structures)
  • Hyaline-type globules
Teratoma[6][7]
  • Unilateral
 Congenital disease such as:
  • May present in both prepubertal and adult men
  • Uncommon in benign ones among prepubertal men

Stains positively for:

- + ↑ ↑ N/A Ultrasound:
Choriocarcinoma[8][9]
  • Most aggressive type
 Early metastasis: Stains positively for: + ± N/A ↑ N/A Ultrasound: style="background: #F5F5F5; padding: 5px;"
Mixed germ cell tumors[10][11]
  • Unilateral
  • Two or more germ cell tumors present as a single mass
  • Depends on underlying components
  • May stain positive based on underlying components
 ± + ↑ ↑ N/A
  • Imaging findings based on underlying components
Carcinoma in situ (intratubular germ cell neoplasia )[12][13][14]
  • Unilateral
  • Bilateral
 Common:

Stain positively for:

- -
  • N/A
 N/A N/A ↑
  • N/A
Diseases Benign/ Malignant Unilateral/Bilateral History Demography Metastasis Genetics Pain Mass Physical exam AFP Beta hCG p-ALP Imaging Histopathology
colspan="15" colspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" Non-germ cell tumors
Leydig cell tumor[15]
  • Unilateral

Stains positively for:

- + N/A N/A N/A Ultrasound:
Sertoli cell tumor ( Androblastoma)[16][17][18]
  • Unilateral
  • Bilateral
  • Occur in any ages (infancy to elderly)
  • Average age of 45 years
  • Mean age for large cell calcifying variant is 21 years old
 Stain positively for: - + N/A N/A N/A Ultrasound:
  • Large cell calcifying variant
  • Hypoechoic
Testicular lymphoma[19][20][21]
  • Unilateral
  • Bilateral ( mostly up to 35% of cases)
  • The most common in men older than 50 years old
 Common metastasis to : Stains positively for: - + ↑ or ↓ ↑ or ↓ N/A Ultrasound:
Granulosa cell tumors[22][23]
  • Unilateral

Juvenile type associated with:

Stains positively for: - + N/A N/A N/A Ultrasound:

References

  1. ↑ Siegel RL, Miller KD, Jemal A (2016). "Cancer statistics, 2016". CA Cancer J Clin. 66 (1): 7–30. doi:10.3322/caac.21332. PMID 26742998.
  2. ↑ Miller FH, Whitney WS, Fitzgerald SW, Miller EI (1999). "Seminomas complicating undescended intraabdominal testes in patients with prior negative findings from surgical exploration". AJR Am J Roentgenol. 172 (2): 425–8. doi:10.2214/ajr.172.2.9930796. PMID 9930796.
  3. ↑ Ishida M, Hasegawa M, Kanao K, Oyama M, Nakajima Y (2009). "Non-palpable testicular embryonal carcinoma diagnosed by ultrasound: a case report". Jpn J Clin Oncol. 39 (2): 124–6. doi:10.1093/jjco/hyn141. PMID 19066212.
  4. ↑ Howitt BE, Berney DM (2015). "Tumors of the Testis: Morphologic Features and Molecular Alterations". Surg Pathol Clin. 8 (4): 687–716. doi:10.1016/j.path.2015.07.007. PMID 26612222.
  5. ↑ Magers MJ, Kao CS, Cole CD, Rice KR, Foster RS, Einhorn LH; et al. (2014). ""Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin". Am J Surg Pathol. 38 (10): 1396–409. doi:10.1097/PAS.0000000000000262. PMID 24921638.
  6. ↑ Simmonds PD, Lee AH, Theaker JM, Tung K, Smart CJ, Mead GM (1996). "Primary pure teratoma of the testis". J Urol. 155 (3): 939–42. PMID 8583612.
  7. ↑ Brosman SA (1979). "Testicular tumors in prepubertal children". Urology. 13 (6): 581–8. PMID 377749.
  8. ↑ Puri S, Sood S, Mohindroo S, Kaushal V (2015). "Cytomorphology of lung metastasis of pure choriocarcinoma of testis in a 58-year-old male". J Cancer Res Ther. 11 (4): 1035. doi:10.4103/0973-1482.154010. PMID 26881635.
  9. ↑ Wood HM, Elder JS (2009). "Cryptorchidism and testicular cancer: separating fact from fiction". J Urol. 181 (2): 452–61. doi:10.1016/j.juro.2008.10.074. PMID 19084853.
  10. ↑ Chuang KL, Liaw CC, Ueng SH, Liao SK, Pang ST, Chang YH; et al. (2010). "Mixed germ cell tumor metastatic to the skin: case report and literature review". World J Surg Oncol. 8: 21. doi:10.1186/1477-7819-8-21. PMC 2851696. PMID 20331874.
  11. ↑ Krag Jacobsen G, Barlebo H, Olsen J, Schultz HP, Starklint H, Søgaard H; et al. (1984). "Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases". Acta Radiol Oncol. 23 (4): 239–47. PMID 6093440.
  12. ↑ Rajpert-De Meyts E, Skakkebaek NE (1994). "Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours". Int J Androl. 17 (2): 85–92. PMID 7517917.
  13. ↑ Jacobsen GK, Nørgaard-Pedersen B (1984). "Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study". Acta Pathol Microbiol Immunol Scand A. 92 (5): 323–9. PMID 6209917.
  14. ↑ Jacobsen GK, Henriksen OB, von der Maase H (1981). "Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: a study of 105 cases". Cancer. 47 (11): 2660–2. PMID 7260858.
  15. ↑ Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM (1998). "Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors". Am J Surg Pathol. 22 (11): 1361–7. PMID 9808128.
  16. ↑ Banerji JS, Odem-Davis K, Wolff EM, Nichols CR, Porter CR (2016). "Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base". J Urol. 196 (4): 1117–22. doi:10.1016/j.juro.2016.03.143. PMID 27036305.
  17. ↑ Young RH (2005). "Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems". Mod Pathol. 18 Suppl 2: S81–98. doi:10.1038/modpathol.3800311. PMID 15502809.
  18. ↑ Gabrilove JL, Freiberg EK, Leiter E, Nicolis GL (1980). "Feminizing and non-feminizing Sertoli cell tumors". J Urol. 124 (6): 757–67. PMID 7003168.
  19. ↑ Shahab N, Doll DC (1999). "Testicular lymphoma". Semin Oncol. 26 (3): 259–69. PMID 10375083.
  20. ↑ Kim J, Abu-Yousef M (2013). "Testicular lymphoma". Ultrasound Q. 29 (3): 247–8. doi:10.1097/RUQ.0b013e3182a0ac0e. PMID 23945480.
  21. ↑ Vega F, Medeiros LJ, Abruzzo LV (2001). "Primary paratesticular lymphoma: a report of 2 cases and review of literature". Arch Pathol Lab Med. 125 (3): 428–32. doi:10.1043/0003-9985(2001)125<0428:PPL>2.0.CO;2. PMID 11231498.
  22. ↑ Garrett JE, Cartwright PC, Snow BW, Coffin CM (2000). "Cystic testicular lesions in the pediatric population". J Urol. 163 (3): 928–36. PMID 10688023.
  23. ↑ Ditonno P, Lucarelli G, Battaglia M, Mancini V, Palazzo S, Trabucco S; et al. (2007). "Testicular granulosa cell tumor of adult type: a new case and a review of the literature". Urol Oncol. 25 (4): 322–5. doi:10.1016/j.urolonc.2006.08.019. PMID 17628299.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Testicular_cancer_differential_diagnosis&oldid=1542505"